Score Breakdown
Offering Ability
42
Cash Runway
40
Float Risk
7
Warrant Exposure
15
Convertible Debt
40
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split
model est. 55%
• 50-day avg $0.87 below $1 exchange minimum
Market Data
Market Cap$38.87M
Shares Outstanding57.61M
Float49.88M
Cash$52.17M
Debt$174.05M
Short InterestN/A
Institutional Holdings
QoQ: ↓ 12.0% shares (2026Q1 vs prior)
63 institutional holders · 22.54M shares
#1
CAS Investment Partners, LLC
5.20M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
4.13M shares
#3
RBF Capital, LLC
1.60M shares
+ 17 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest645.2K
Days to Cover16.0
% of Float1.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2023-12-31
xbrl
XBRL CONVERTIBLE
2022-12-31
4
INSIDER TRANSACTION
2026-04-06
4
INSIDER TRANSACTION
2026-04-02
4
INSIDER TRANSACTION
2026-04-02
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual CDLX Dilution Snapshot
Cardlytics, Inc. (CDLX) has a DilutionScore of 32/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for CDLX: 4 on 2026-04-06; 4 on 2026-04-02; 4 on 2026-04-02.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles: